Login to Your Account

ABPI: Cost Savings Shouldn't Trump Health Care Innovation

By Nuala Moran
Staff Writer

Wednesday, May 2, 2012
LONDON – The industry in the UK is hitting back at government cuts to the drugs bill, setting up a task force to liaise with National Health Service (NHS) payers and promote the use of innovative drugs.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription